We could recently show that compared to healthy controls, TGFβ and its receptor TGFβ-RII are upregulated in post mortem CNS tissue of ALS patients [14] and that stem cell niche activity is subsequently decreased in the brain and SC. The gene discussed is TGFB1; the disease is amyotrophic lateral sclerosis.